Article
Epidemiology and treatment outcomes of patients with chronic hepatitis C and genotypes 4 to 9.
Reviews in gastroenterological disorders - 1 Jan 2004
Nguyen Mindie H, Keeffe Emmet B
Abstract excerpt
Pivotal clinical trials of antiviral therapy for chronic hepatitis C have been conducted predominantly in Europe and the United States, where most patients are infected with genotypes 1, 2, or 3. As a result, published data on the outcomes of therapy in patients infected with genotypes 4, 5, and 6 to 9 are limited. However, a major proportion of patients with chronic hepatitis C worldwide reside in geographic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
